Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSCs in ADPKD
NCT02166489Phase 1Completed
- Sponsor
- Royan Institute
- Start
- Mar 2014
- Primary completion
- Dec 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of autologous bone marrow mesenchymal stromal cells in autosomal dominant polycystic kidney disease (ADPKD), sponsored by Royan Institute. Primary endpoint: Mass formation at 1 month. Started Mar 2014; status: completed.
02
Drugs
autologous bone marrow mesenchymal stromal cells
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT02166489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02166489.